A phase III, randomized, placebo-controlled trial of adjuvant nivolumab plus ipilimumab in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after radical or partial nephrectomy (CheckMate 914)
Bex, A., Grünwald, V., Russo, P., Tomita, Y., Berghorn, E., McHenry, M.B., Motzer, R.J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy
Hausheer, Frederick H, Schilsky, Richard L, Bain, Stacey, Berghorn, Elmer J, Lieberman, Frank
Published in Seminars in oncology (01.02.2006)
Published in Seminars in oncology (01.02.2006)
Get more information
Journal Article
Evaluation of the relationship between cetuximab therapy and corrected QT interval changes in patients with advanced malignancies from solid tumors
Deeken, J. F., Shimkus, B., Liem, A., Hill, D., Gurtler, J., Berghorn, E., Townes, L., Lu, H., Trifan, O., Zhang, S.
Published in Cancer chemotherapy and pharmacology (01.06.2013)
Published in Cancer chemotherapy and pharmacology (01.06.2013)
Get full text
Journal Article
Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine
Budman, D R, Meropol, N J, Reigner, B, Creaven, P J, Lichtman, S M, Berghorn, E, Behr, J, Gordon, R J, Osterwalder, B, Griffin, T
Published in Journal of clinical oncology (01.05.1998)
Published in Journal of clinical oncology (01.05.1998)
Get more information
Journal Article
927TiPA phase III, randomized, placebo-controlled trial of adjuvant nivolumab plus ipilimumab in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after radical or partial nephrectomy (CheckMate 914)
Bex, A, Grünwald, V, Russo, P, Tomita, Y, Berghorn, E, McHenry, M B, Motzer, R J
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
PCN187 - Overall Survival, Health-Related Quality of Life, and Healthcare Resource Use: Independent Analyses from Checkmate 025, A Phase Iii Study of Nivolumab Versus Everolimus in Patients with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma
Taylor, F, Dastani, H, Bennett, B, DeRosa, M, Berghorn, E, Justin, D
Published in Value in health (01.05.2016)
Published in Value in health (01.05.2016)
Get full text
Journal Article
Overall Survival, Health-Related Quality of Life, and Healthcare Resource Use: Independent Analyses from Checkmate 025, A Phase Iii Study of Nivolumab Versus Everolimus in Patients with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma
Taylor, F, Dastani, H, Bennett, B, DeRosa, M, Berghorn, E, Justin, D
Published in Value in health (01.05.2016)
Published in Value in health (01.05.2016)
Get full text
Journal Article
Paclitaxel and carboplatin in early phase studies: Roswell Park Cancer Institute experience in the subset of patients with lung cancer
Creaven, P J, Raghavan, D, Pendyala, L, Loewen, G, Kindler, H L, Berghorn, Jr, E J
Published in Seminars in oncology (01.08.1997)
Get more information
Published in Seminars in oncology (01.08.1997)
Journal Article
Early phase studies with paclitaxel/low-dose carboplatin in patients with solid tumors
Creaven, P J, Raghavan, D, Perez, R P, Pendyala, L, Berghorn, Jr, E J, Loewen, G, Meropol, N J
Published in Seminars in oncology (01.12.1996)
Get more information
Published in Seminars in oncology (01.12.1996)
Journal Article
Phase II Trial of Karenitecin in Patients with Malignant Melanoma: Clinical and Translational Study
DAUD, Adil, VALKOV, Nikola, HAUSHEER, Frederick, SULLIVAN, Daniel, CENTENO, Barbara, DERDERIAN, Jennifer, SULLIVAN, Patricia, MUNSTER, Pamela, URBAS, Patricia, DECONTI, Ronald C, BERGHORN, Elmer, ZHENMEI LIU
Published in Clinical cancer research (15.04.2005)
Published in Clinical cancer research (15.04.2005)
Get full text
Journal Article
Phase II trial of karenitecin (BNP1350) in malignant: Clinical and translational study
Hausheer, F. H., Berghorn, E., Liu, Z., Sullivan, D., Centeno, B., Derderian, J., Deconti, R., Daud, A., Sullivan, P., Andrews, S.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Phase II trial of karenitecin (BNP1350) in malignant: Clinical and translational study
Hausheer, F. H., Berghorn, E., Liu, Z., Sullivan, D., Centeno, B., Derderian, J., Deconti, R., Daud, A., Sullivan, P., Andrews, S.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Final results of a phase I and pharmacokinetic study of γ-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors
JOHANSEN, Mary, ZUKOWSKI, Thomas, HOFF, Paulo M, NEWMAN, Robert A, DAN NI, HUTTO, Toni, ABBRUZZEESE, James, BERGHORN, Elmer, HAUSHEER, Frederick, MADDEN, Timothy
Published in Cancer chemotherapy and pharmacology (01.05.2004)
Published in Cancer chemotherapy and pharmacology (01.05.2004)
Get full text
Journal Article
Unusual central nervous system toxicity in a phase I study of N1N11diethylnorspermine in patients with advanced malignancy
CREAVEN, P. J, PEREZ, R, PENDYALA, L, MEROPOL, N. J, LOEWEN, G, LEVINE, E, BERGHORN, E, RAGHAVAN, D
Published in Investigational new drugs (01.09.1997)
Published in Investigational new drugs (01.09.1997)
Get full text
Journal Article
A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patient with colorectal carcinoma
Meropol, N J, Petrelli, N J, Rustum, Y M, Rodriguez-Bigas, M, Blumenson, L E, Frank, C, Berghorn, E, Creaven, P J
Published in Investigational new drugs (1995)
Get more information
Published in Investigational new drugs (1995)
Journal Article